siRNA therapy lowers triglycerides in clients with uncommon problem

.RESEARCH EMPHASIZE.19 September 2024.

Plozasiran decreased triglyceride levels by 80% and also lowered the danger of pancreatitis in individuals with consistent chylomicronemia, with or without a hereditary diagnosis.